相关实验视频
Updated: May 11, 2026
11:37
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
13.8K
授权引导的自助干预治疗乳腺癌症状负担 妇女接受卵巢功能抑制治疗:随机试验协议
Yuan Li1, Yun Yun Chen2, Su Xing Wang3
1School of Nursing, Shanghai Jiao Tong University, Shanghai, China.
World journal of oncology
|March 28, 2024
概括
这项研究调查了指导性自助干预措施,用于管理乳腺癌患者的症状负担,这些患者正在接受卵巢功能抑制 (OFS) 治疗. 早期干预是改善患者结果和生存效益的关键.
科学领域:
- 在瘤学瘤学.
- 护理 护理 护理
- 心理社会瘤学
背景情况:
- 乳腺癌患者的卵巢功能抑制 (OFS) 导致雌激素的快速下降,导致显著的身体和心理症状负担.
- OFS治疗的5年持续时间和循环性质加剧了症状负担,可能会影响生存效益.
- 有效的症状管理是至关重要的,但OFS特定的自我管理策略尚未发展,突出显示了支持性护理方面的差距.
研究的目的:
- 评估基于赋权理论的指导自助 (GSH) 干预措施的有效性,用于管理早期OFS治疗乳腺癌患者的症状负担.
- 探索GSH对OFS治疗初始阶段症状负担和相关指标的影响.
主要方法:
- 一个前性的,双臂,并行,随机控制,单盲临床试验,涉及144名接受OFS治疗的乳腺癌患者.
- 患者被随机分配,接受授权GSH干预 (两轮,15周五次) 或通常的护理护理.
- 症状负担和相关结果在基线和治疗开始后的1,3,6个月被评估.
主要成果:
- (结果尚未提供,因为这是一个协议/计划.)
结论:
- 预计这些发现将验证GSH作为乳腺癌早期OFS治疗症状负担管理的有效策略.
- 这项研究旨在提高对整个OFS治疗连续性的症状负担管理的理解.
- 该研究可以通过提供基于证据的指导方针来为OFS治疗的乳腺癌患者提供支持性护理,从而为临床实践提供信息.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...